MF-438
CAS No. 921605-87-0
MF-438( —— )
Catalog No. M22502 CAS No. 921605-87-0
MF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 132 | In Stock |
|
5MG | 203 | In Stock |
|
10MG | 311 | In Stock |
|
25MG | 527 | In Stock |
|
50MG | 754 | In Stock |
|
100MG | 1044 | In Stock |
|
500MG | 2088 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMF-438
-
NoteResearch use only, not for human use.
-
Brief DescriptionMF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.
-
DescriptionMF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorSCD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number921605-87-0
-
Formula Weight421.44
-
Molecular FormulaC19H18F3N5OS
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (148.30 mM; Need ultrasonic)
-
SMILESCc1nnc(s1)-c1ccc(nn1)N1CCC(CC1)Oc1ccccc1C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Léger S, et al. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Bioorg Med Chem Lett. 2010 Jan 15;20(2):499-502.
molnova catalog
related products
-
MF-438
MF-438 is an effective and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhibitor (EC50: 2.3 nM for rSCD1). In a mouse model, MF-438 shows an ED50 between 1 and 3 mg/kg.
-
Propachlor
Propachlor is an inhibitor of ALDH1A1is an acetamide herbicide used in preemergence.
-
IDH1-IN-1
Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 uM(A level in Patent).